A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The analysis of rich catalogues of genetic variation from population-based sequencing provides an opportunity to screen for functional effects. Here we report a rare variant in APOC3 (rs138326449-A, minor allele frequency ~0.25% (UK)) associated with plasma triglyceride (TG) levels (−1.43 s.d. (s.e.=0.27 per minor allele (P-value=8.0 × 10−8)) discovered in 3,202 individuals with low read-depth, whole-genome sequence. We replicate this in 12,831 participants from five additional samples of Northern and Southern European origin (−1.0 s.d. (s.e.=0.173), P-value=7.32 × 10−9). This is consistent with an effect between 0.5 and 1.5 mmol l−1 dependent on population. We show that a single predicted splice donor variant is responsible for association signals and is independent of known common variants. Analyses suggest an independent relationship between rs138326449 and high-density lipoprotein (HDL) levels. This represents one of the first examples of a rare, large effect variant identified from whole-genome sequencing at a population scale.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes
Siepel, A., Bejerano, G., Pedersen, J. S., Hinrichs, A. S., Hou, M., Rosenbloom, K., Clawson, H., Spieth, J., Hillier, L. W., Richards, S., et al. (2005) · Genome Research · doi:10.1101/gr.3715005 · Cited by 3,971 · cited 1×
“…e r s A u t ho r M a nu s c r i p t s dataset, we note that this position is highly conserved (phastCons = 0.996, a measurement of evolutionary conservation based on multiple alignments of 100 vertebrates) through vertebrates 33 , supporting a likely potential functional consequence for this site.”
InfluentialHowie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928
Genome-wide efficient mixed-model analysis for association studies
Zhou, X., & Stephens, M. (2012) · Nature Genetics · doi:10.1038/ng.2310 · Cited by 3,627 · cited 1×
“2 software package 54 , apart for the TwinsUK GWAS and HELIC MANOLIS datasets where mixed linear models were used to account for family structure using the GEMMA software 55 .”
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationIntegrating common and rare genetic variation in diverse human populations
The International HapMap 3 Consortium (2010) · Nature · doi:10.1038/nature09298 · Cited by 3,026
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
The mystery of missing heritability: Genetic interactions create phantom heritability
Zuk, O., Hechter, E., Sunyaev, S. R., & Lander, E. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119675109 · Cited by 1,542 · cited 1×
“This may be contributed to by smaller common variant effects, as yet undiscovered rare and potentially functional genetic variation, gene by gene interaction (epistasis) or by overestimates of heritability 5 .”
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Self-citationHuman Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
Drmanac, R., Sparks, A. B., Callow, M. J., Halpern, A. L., Burns, N. L., Kermani, B. G., Carnevali, P., Nazarenko, I., Nilsen, G. B., Yeung, G., et al. (2010) · Science · doi:10.1126/science.1181498 · Cited by 1,212 · cited 1×
“…panels for imputing three SNP array data, a sub-sample of 1000 individuals from the UK10K WGS dataset, four European samples (3 CEU, 1 TSI) sequenced by Complete Genomics (CG, depth: 80X) 52 , and an Italian isolate genotyped on core-exome SNP array (see Supplementary Methods for full details).”
Self-citation
Cited by
The UK10K project identifies rare variants in health and disease
The UK10K Consortium, Writing group, Walter, K., Min, J. L., Huang, J., Crooks, L., Memari, Y., McCarthy, S., Perry, J. R. B., Xu, C., et al. (2015) · Nature · doi:10.1038/nature14962 · Cited by 1,040
Self-citationDewey, F. E., Murray, M. F., Overton, J. D., Habegger, L., Leader, J. B., Fetterolf, S. N., O’Dushlaine, C., Van Hout, C. V., Staples, J., Gonzaga-Jauregui, C., et al. (2016) · Science · doi:10.1126/science.aaf6814 · Cited by 548
Genetic architecture: the shape of the genetic contribution to human traits and disease
Timpson, N. J., Greenwood, C. M. T., Soranzo, N., Lawson, D. J., & Richards, J. B. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.101 · Cited by 434
Self-citationThe impact of rare and low-frequency genetic variants in common disease
Bomba, L., Walter, K., & Soranzo, N. (2017) · Genome Biology · doi:10.1186/s13059-017-1212-4 · Cited by 344
Self-citationMendelian randomization: where are we now and where are we going?
Burgess, S., Timpson, N. J., Ebrahim, S., & Davey Smith, G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv108 · Cited by 304
Self-citationApolipoprotein C-III: from pathophysiology to pharmacology
Norata, G. D., Tsimikas, S., Pirillo, A., & Catapano, A. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.001 · Cited by 182
“However, other rare variants of the APOC3 gene were associated with decreased TG and increased HDL-C levels, but not with changes in LDL-C or total cholesterol levels [90].”
BackgroundXu, L., Borges, M. C., Hemani, G., & Lawlor, D. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4396-y · Cited by 104
“Furthermore, a rare variant in APOC3 with a marked effect on triacylglycerol levels provides a potential target for drug development aimed at reducing triacylglycerol levels, independent of any statin effects [38, 39].”
BackgroundPan, B.-Y., Chen, C.-S., Chen, F.-Y., & Shen, M.-Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312759 · Cited by 19
Metadata
- Authors
- Timpson, N. J., Walter, K., Min, J. L., Tachmazidou, I., Malerba, G., Shin, S.-Y., Chen, L., Futema, M., Southam, L., Iotchkova, V., Cocca, M., Huang, J., Memari, Y., McCarthy, S., Danecek, P., Muddyman, D., Mangino, M., Menni, C., Perry, J. R. B., Ring, S. M., Gaye, A., Dedoussis, G., Farmaki, A.-E., Burton, P., Talmud, P. J., Gambaro, G., Spector, T. D., Smith, G. D., Durbin, R., Richards, J. B., Humphries, S. E., Zeggini, E., Soranzo, N., UK1OK consortium members, Al Turki, S., Anderson, C., Anney, R., Antony, D., Soler Artigas, M., Ayub, M., Balasubramaniam, S., Barrett, J. C., Barroso, I., Beales, P., Bentham, J., Bhattacharya, S., Birney, E., Blackwood, D., Bobrow, M., Bochukova, E., Bolton, P., Bounds, R., Boustred, C., Breen, G., Calissano, M., Carss, K., Chatterjee, K., Chen, L., Ciampi, A., Cirak, S., Clapham, P., Clement, G., Coates, G., Collier, D., Cosgrove, C., Cox, T., Craddock, N., Crooks, L., Curran, S., Curtis, D., Daly, A., Danecek, P., Davey Smith, G., Day-Williams, A., Day, I. N. M., Down, T., Du, Y., Dunham, I., Durbin, R., Edkins, S., Ellis, P., Evans, D., Faroogi, S., Fatemifar, G., Fitzpatrick, D. R., Flicek, P., Flyod, J., Foley, A. R., Franklin, C. S., Futema, M., Gallagher, L., Gaunt, T., Geihs, M., Geschwind, D., Greenwood, C., Griffin, H., Grozeva, D., Guo, X., Guo, X., Gurling, H., Hart, D., Hendricks, A., Holmans, P., Howie, B., Huang, J., Huang, L., Hubbard, T., Humphries, S. E., Hurles, M. E., Hysi, P., Jackson, D. K., Jamshidi, Y., Jing, T., Joyce, C., Kaye, J., Keane, T., Keogh, J., Kemp, J., Kennedy, K., Kolb-Kokocinski, A., Lachance, G., Langford, C., Lawson, D., Lee, I., Lek, M., Liang, J., Lin, H., Li, R., Li, Y., Liu, R., Lönnqvist, J., Lopes, M., Lotchkova, V., MacArthur, D., Marchini, J., Maslen, J., Massimo, M., Mathieson, I., Marenne, G., McCarthy, S., McGuffin, P., McIntosh, A., McKechanie, A. G., McQuillin, A., Memari, Y., Metrustry, S., Min, J., Mitchison, H., Moayyeri, A., Morris, J., Muddyman, D., Muntoni, F., Northstone, K., O'Donnovan, M., Onoufriadis, A., O'Rahilly, S., Oualkacha, K., Owen, M. J., Palotie, A., Panoutsopoulou, K., Parker, V., Parr, J. R., Paternoster, L., Paunio, T., Payne, F., Perry, J., Pietilainen, O., Plagnol, V., Quaye, L., Quail, M. A., Raymond, L., Rehnström, K., Richards, B., Ring, S., Ritchie, G. R. S., Roberts, N., Savage, D. B., Scambler, P., Schiffels, S., Schmidts, M., Schoenmakers, N., Semple, R. K., Serra, E., Sharp, S. I., Shihab, H., Shin, S.-Y., Skuse, D., Small, K., Soranzo, N., Southam, L., Spasic-Boskovic, O., Spector, T., St Clair, D., Stalker, J., Stevens, E., St Pourcian, B., Sun, J., Surdulescu, G., Suvisaari, J., Tachmazidou, I., Timpson, N., Tobin, M. D., Valdes, A., Van Kogelenberg, M., Vijayarangakannan, P., Visscher, P. M., Wain, L. V., Walter, K., Walters, J. T. R., Wang, G., Wang, J., Wang, Y., Ward, K., Wheeler, E., Whyte, T., Williams, H., Williamson, K. A., Wilson, C., Wilson, S. G., Wong, K., Xu, C., Yang, J., Zeggini, E., Zhang, F., Zhang, P., & Zheng, H.-F.
- Venue
- Nature Communications
- Published
- 2014-09-16
- Volume
- 5
- Issue
- 1
- Pages
- 4871-4871
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2132992776
- Cited by
- 68
- References
- 18
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.